key: cord-1052656-rtkthg28 authors: Zhang, Cindy X.W.; Okeke, Justin C.; Levitan, Robert D.; Murphy, Kellie E.; Foshay, Kim; Lye, Stephen J.; Knight, Julia A.; Matthews, Stephen G. title: Evaluating Depression and Anxiety Throughout Pregnancy and Postpartum: Impact of the COVID-19 Pandemic date: 2022-03-04 journal: Am J Obstet Gynecol MFM DOI: 10.1016/j.ajogmf.2022.100605 sha: bee0d3fcd533ad922c87fd6964fb4389e23517e1 doc_id: 1052656 cord_uid: rtkthg28 Background The COVID-19 pandemic presents unique social, economic, and psychological challenges for individuals globally. As a result, individuals who are pregnant face unprecedented mental health challenges. Objectives We sought to determine the impact of the pandemic on perinatal depression and anxiety in a longitudinal pregnancy cohort. We hypothesized increased depression and anxiety scores in individuals during pregnancy and postpartum in the pandemic at all time points. Study Design Participants were enrolled in the Ontario Birth Study (OBS), a pregnancy cohort embedded in clinical care at Mount Sinai Hospital, Toronto. Perinatal depression and anxiety were assessed using the Patient Health Questionnaire-2 (PHQ-2) and Generalized Anxiety Disorder Questionnaire-2 (GAD-2) in early pregnancy while the Edinburgh Postnatal Depression Scale (EPDS) and GAD-2 were used in late pregnancy and postpartum. Logistic regression models were created to examine the association of the pandemic with clinically elevated mental health scores in pre-pandemic vs. during pandemic groups while adjusting for covariates. Results 1159 survey responses from 649 participants between March 1, 2019, to February 28, 2021, were used to conduct this study. Participants were assessed in early pregnancy (416), in late pregnancy (373), and postpartum (370). Responses received on or prior to February 29, 2020, were considered the “pre-pandemic” group, while responses after were considered the “pandemic” group. Mean rank scores of depression and anxiety were significantly higher in the pandemic group (p=0.02, p=0.003) in the postpartum period. There was no significant association between pandemic time and antenatal scores. However, postnatally, mothers were 2.6 times more likely to score 13 or above on the EPDS during the pandemic than pre-pandemic (95% CI= 1.2-5.7, p=0.02). Adjustment for ethnicity and income strengthened this association as the odds ratio increased to 3.3 (95% CI= 1.4-8.0, p=0.007). Conclusion Pandemic-associated increases in depression and anxiety scores were confined to the postpartum period, highlighting a need for increased screening and interventions for Perinatal Mood and Anxiety Disorders postnatally as this pandemic continues. The Coronavirus Disease 2019 (COVID-19) remains a rapidly evolving situation that has dramatically changed the global healthcare landscape. Beyond the immediate health consequences of a major viral outbreak, there have been profound psychological, economic, and social consequences as people are forced to leave their jobs and to isolate from their families, friends, and communities. The United States Centers for Disease Control and Prevention reported that 40% of adults experienced mental health problems during this pandemic and up to 31% experienced depression and anxiety 1 . Symptoms of depression, anxiety, and psychological distress are reported more frequently by women than men during large-scale disease outbreaks 2 such as during the 2003 Severe Acute Respiratory Syndrome (SARS) outbreak 3 and is currently being observed during the COVID-19 pandemic 4 . This is especially concerning in the pregnant population as perinatal psychological distress can lead to negative health outcomes not only for the birthing parent and child 5 but can also cause spousal/partner stress 6 , induce household instability for siblings 7 , and contribute to economic burden on a societal level 8 . During pregnancy, an individual undergoes substantial physiological and psychological changes which put them at a higher risk of experiencing distressing feelings, referred to as Perinatal Mood and Anxiety Disorders (PMAD) 9 . An estimated 13-21% of pregnant individuals experience PMAD which most commonly presents as depression and anxiety but also includes obsessive compulsive disorder, and post-traumatic stress disorder 10 . The current research will focus on depression and anxiety when referring to PMAD. There has been a push for routine clinical PMAD screening for all those receiving prenatal care with more consistent follow-up 11 because as many as half of those with PMAD are not identified 12 . The symptomology of perinatal depression overlap heavily with major depressive disorder but they differ in their onset as PMAD is triggered by pregnancy 13 . Further, anxiety disorders are still highly co-morbid with depression even during the perinatal period 14 . Some of the risk factors for developing PMAD are low socioeconomic status, exposure to interpersonal or domestic violence, and lack of social support 15 . These risk factors can be exacerbated by the stressors associated with the COVID-19 pandemic which has the potential to increase the incidence of PMAD in an already high-risk group. There is strong evidence for links between PMAD and adverse birth outcomes such as preterm birth, intrauterine growth restriction 16, 17 , decreased mother-infant bonding, and delayed infant cognitive and emotional development 18, 19 . Consequently, the effects of in utero exposure to PMAD can be observed in infancy and into adulthood [20] [21] [22] . It has been postulated that the dysregulation of cortisol during pregnancy while depressive symptoms are occurring is one of the mechanisms contributing to the increased behavioral problems seen in children. Cortisol is able to cross the placenta to influence the developing fetal hypothalamic-pituitary-adrenal axis and limbic system, subsequently affecting emotional reactivity in children 23 . Similarly, anxiety during pregnancy has been shown to have a negative impact on executive function in children. Higher state anxiety during pregnancy was associated with lower visuospatial working memory performance at 6-9 years of age 24 . Postpartum depression has a prevalence of 10-15% 25 and this condition hinders mother-infant bonding which creates an adverse environment for optimal child neurodevelopment. It has been strongly associated with poor offspring cognitive functioning, behavioral inhibition, emotional maladjustment, and psychiatric disorder risk in later-life [14] [15] [16] . Although research has focused predominantly on postpartum depression, postpartum anxiety has also been related to negative offspring psychological outcomes such as increased behavioural and emotional problems 22, 26 . Pregnant individuals may be at higher risk for PMAD during pandemic conditions due to the lifestyle restrictions, financial uncertainty, and stress from decreased social support and childcare. Racine This study was approved by the Mount Sinai Hospital Research Ethics Board, Toronto, Ontario. Through the OBS, all participants provided written informed consent for their participation in both study components and access to their clinical data for research. Institute and Mount Sinai Hospital, Toronto. There are approximately 7,000 deliveries per year at Mount Sinai Hospital. Individuals less than 17-weeks gestational age, English speaking, and at least 18-years old are eligible to participate. Data from lifestyle questionnaires (LSQs), diet questionnaires, clinical records, and biospecimens are collected throughout pregnancy, using methodology as described previously 29 . The LSQs are administered in early pregnancy (12-16 weeks gestational age), late pregnancy (24-28 weeks gestational age) and postnatally (6-10 weeks postpartum). The LSQs collect data on previous pregnancies, mental health, demographics, lifestyle, and environmental exposures. To investigate the potential effects of the pandemic on mental health, we analysed LSQ responses received in the year prior to and during the COVID-19 pandemic between March 1, 2019, and February 28, 2021. Responses received on or prior to Feb 29, 2020, were considered the "pre-pandemic" group, and responses from March 1, 2021, onward, were considered the "pandemic" group. Questionnaire response rates were 92.2% pre-pandemic and 95.1% during the pandemic in early pregnancy; 81.2% pre-pandemic and 75.9% during the pandemic in late pregnancy; and 65.4% pre-pandemic and 53.1% during the pandemic in the postpartum period. All depression and anxiety measures were embedded into each LSQ. Anxiety was measured with the 2-item Generalized Anxiety Disorder Questionnaire (GAD-2) at all time points. The GAD-2 was derived from the 7-item GAD. A GAD-2 score ≥ 3 indicates clinically elevated anxiety with 83% sensitivity and 90% specificity 38 . Depression in early pregnancy was assessed by the 2-item patient health questionnaire (PHQ-2), derived from the 9-item PHQ and PRIME-MD. A PHQ-2 score ≥ 3 can be used to screen for major depression with 83% sensitivity and 92% specificity 39 . The late pregnancy and postnatal questionnaires included the Edinburgh Postnatal Depression Scale (EPDS), a 10-item instrument commonly used in prenatal care for depression screening. The EPDS is the most used depression screening tool in postnatal care. It has a scale of 0-30 and individuals who score ≥ 13 are considered likely to be suffering from perinatal depression. This screening tool with cut-off value ≥ 13 has 66% sensitivity and 95% specificity 40 . Clinical literature has shown that cut-off values of 11 and 13 are both valid; however, we chose to use the higher symptom levels of perinatal depression with greater specificity and somewhat lower sensitivity 30 . A 3-question anxiety-focused derivative of the EPDS (EPDS-3A) was also used to examine anxiety at the late pregnancy and postpartum time points. A cut-off of ≥5 was used to identify persons experiencing clinically elevated anxiety which has a sensitivity of 70.9% and specificity of 92.2% 31 . Initial analyses involved the comparisons of depression and anxiety scores for each demographic variable. The primary demographic characteristics evaluated were age, BMI, education, ethnicity, income, and parity. The Kendall's Tau-B correlation coefficient was used to assess the association of continuous demographic variables with maternal mental health scores. Maternal mental health scores were compared for categorical demographic variables using the Mann-Whitney U-test or the Kruskal Wallis H-test. Maternal depression and anxiety scores pre-pandemic and during the pandemic were directly compared using Mann-Whitney U-tests. Chi-square tests were used to test the association between pandemic time and depression and anxiety scores above the clinical cut-off: PHQ-2 and GAD-2 scores ≥ 3, EPDS-3A scores ≥ 5 and EPDS scores ≥ 13 regardless of whether the participant endorsed suicidal ideation. Further, logistic regression models were created to examine the associations of pandemic timing (before or during the pandemic) with clinically relevant maternal depression and anxiety scores, adjusting for covariates. Any demographic characteristic significantly associated with depression and/or anxiety scores consistently at multiple time points during pregnancy and postnatally were included in all the final multivariable logistic regression models. Thus, only income and ethnicity were included as covariates. Individuals missing either of these were excluded from the analyses. Statistical analysis was conducted Table 1 . Most participants were Caucasian and primiparous with a mean pre-pregnancy BMI of 23.7-23.9 across all groups. The study population was generally highly educated with most participants having a bachelor's degree or higher. Depression scores in early pregnancy (p<0.001) and depression and anxiety scores postnatally (p=0.02 and p=0.006, respectively) differed significantly by ethnicity with higher scores in non-Caucasians compared to Caucasians. Depression and anxiety scores were significantly different between income levels (< $100,000, $100,000-149,999, and ≥ $150,000) at all time points: early pregnancy (p<0.001 and p=0.003, respectively), late pregnancy (p<0.001 and p=0.05, respectively), and postpartum (p=0.001 and p=0.01, respectively). The mean ranks of depression scores were the highest in the lowest income category (<$100,000) compared to both upper income categories ($100,000-150,000 and >$150,000) in early pregnancy (p=0.008 and p<0.001, respectively), late pregnancy (p=0.002 and p<0.001, respectively), and postpartum (p=0.008 and p=0.001, respectively). Participant anxiety scores were also highest in the lowest income category compared to $100,000-150,000 and >$150,000 in early pregnancy (p=0.04 and p=0.001, respectively) and postpartum (p=0.02 and p=0.01, respectively). Primiparous mothers reported higher depression scores (p = 0.002) and anxiety scores (p=0.03) than multiparous mothers postnatally, and higher depression scores in late pregnancy (p=0.04). Participant age was inversely associated with anxiety scores only in the postpartum period (r= -0.13, p=0.01), but was not related to depression scores at any time point. Depression and anxiety scores did not differ between BMI categories. The means, medians, and mean ranks of maternal depression and anxiety scores before and during the pandemic are shown in Table 2 . Both mean and median scores were well below clinical cut-off values in all groups. Direct pandemic time comparisons of maternal depression and anxiety scores revealed higher mean ranks of depression scores during the pandemic compared to pre-pandemic (208.7 and 178.6, respectively) in the postpartum period (p=0.02). Similarly, mean ranks of maternal anxiety scores were significantly higher during the pandemic compared to pre-pandemic (203.8 and 177.4, respectively) in the postpartum period (p=0.03). There were no significant differences between either maternal depression or maternal anxiety scores before and during the pandemic in early or late pregnancy. The distribution of maternal depression and anxiety scores at all time points are shown in Figure 1 . Table 3 provides the unadjusted and adjusted results of the logistic regression models where in the adjusted model, ethnicity and income are also included. In early and late pregnancy, both the unadjusted and adjusted models showed no significant association between pandemic time and maternal depression or anxiety scores. However, in the postpartum unadjusted model, mothers were 2.6 times more likely to report clinically elevated depression scores during the pandemic (95% CI= 1.2-5.7, p=0.02). This association strengthened after adjusting for ethnicity and income as the odds ratio increased to 3.3 (95% CI= 1.4-8.0, p=0.007). Similarly, study participant anxiety as measured by the EPDS-3A was higher during the pandemic only in the postpartum period. In the unadjusted model, participants were 1.8 times more likely to experience clinically elevated anxiety scores (95% CI= 1.1-3.1, p=0.02). This association was stronger after adjusting for covariates with an increased odds ratio of 2.1 (95% CI= 1.2-3.7, p=0.009). The current study advances our understanding of how the COVID-19 pandemic has contributed to PMAD. Unexpectedly, in this longitudinal pregnancy cohort, the effect of pandemic conditions on increasing depression scores was limited to the postpartum period. This suggests that prevention and treatment interventions that target postpartum depression and anxiety are a high priority during pandemic times. Like other forms of depression, postpartum depression is multifactorial in nature with genetics, psycho-social factors, and circadian rhythm disruption all playing a significant role 32 . Fewer studies have examined postpartum anxiety, but most attribute its incidence to the same mechanisms as depression due to their comorbidity 33 .While we cannot determine the specific mechanisms to account for the current findings, it is of note that diminished social support and sleep have been linked to pandemic-related depression in recent work 34, 35 . It is highly plausible that postpartum depression may be particularly sensitive to these effects. In contrast to previous studies 28 but similar to our findings, Zilver et al. 36 did not observe an effect of COVID-19 on PMAD during pregnancy. Although related, the risk factor profiles differ between antenatal and postnatal depression whereby the largest predictor of antenatal depression is low selfesteem and anxiety while the largest predictor for postnatal depression is parenting stress 37 . An international collaboration (including 64 countries) found that the most commonly reported worries for birthing parents during the COVID-19 pandemic were related to family and social support post-delivery as well as inadequate childcare and the risk of their child contracting COVID-19 as this pandemic continues 38 . These results are in line with our findings as we observed an association of the pandemic with PMAD that was confined to the postnatal period. In other studies, birthing parents reported that the perception of decreased social and informal support from family and friends due to pandemic restrictions was a negative psychosocial outcome of the COVID-19 pandemic 39 . Several other recent studies have evaluated the role of perceived social support during the pandemic. Those who reported higher levels of perceived social support also reported lower levels of depression and anxiety alongside improved sleep quality 35 . Kent de Grey et al., 40 proposed improved sleep quality as one pathway through which social support could promote health. They argued that the positive aspects of social support such as the feeling or perception of belonging or being valued can elevate mood and decrease anxiety to improve sleep quality. Of all the physiological changes experienced by mothers in the perinatal period, increased sleep disturbance is often disregarded. Mothers who experience increased insomnia or sleep disturbance are more likely to experience depressive symptomatology or postpartum depression 41, 42 . According to Elsenbruch et al. 43 , pregnant women with low social support lack effective psychosocial resources as they have less social participation and insufficient emotional and instrumental support. In addition, the postpartum period represents an important and stressful life change for mothers. These conditions can lead to a hypersecretion of cortisol, which has been considered a biological risk factor of depression 44 . Although both primiparous and multiparous mothers are affected by PMAD, primiparous mothers in the early postnatal period may be more vulnerable to psychosocial challenges. In addition to experiencing physiological changes, they must navigate their new role as a mother with their partner, extended family and healthcare professionals 39 . It has been suggested that the COVID-19 pandemic has magnified social and economic inequalities for mothers with mental health problems 45 . As many of the OBS participants are highly educated people in the upper income bracket, it is plausible that they had more job and income stability during the pandemic and therefore, would not have been as susceptible to this risk factor during pregnancy as lower income women. However, social support is a major buffer for postpartum depression pandemic. Mothers reported feeling "cheated" out of their postpartum resources such as doulas and early child-rearing classes after receiving prenatal care during pregnancy. When we accounted for income in the analysis, the relationship between pandemic timing and both depression and anxiety scores in the postpartum period became even stronger. Women participating in the Ontario Birth Study (OBS) have the option to enroll their child into OBS Kids, which collects early child development information and biospecimens from birth to 4-years. Future studies will assess whether maternal mental health scores relate to child developmental outcomes. A major strength of the present research was the opportunity to examine a study population recruited from the same hospital both before and during the pandemic. Additional value is provided by the availability of data at multiple perinatal time points. The OBS continued recruitment through most of the pandemic allowing the generation of a substantial prenatal sample size for analysis. A limitation was the relatively small size of the postpartum group during the pandemic. In general, questionnaire response rates are lower in the postpartum period as new parents are dealing with other challenges. In addition, although we were able to continue following those already recruited and to re-start recruitment, there was an unavoidable approximate 3-month gap in recruitment. Another limitation is that maternal mental health was self-reported via questionnaires. Ideally, these measures would be verified with a thorough clinical assessment. However, all the assessments utilized were established, validated tools. The perinatal period is a sensitive time during which intrauterine exposures or impaired parental caregiving can alter development of key infant organ systems leading to long-term effects on neurologic and cardiometabolic function. In addition, PMADs can result in stress for spouses or partners, affect other children in the household, and become a financial burden due to impacting an individual's ability to work. To our knowledge, ours is one of the first studies to evaluate the association of the COVID-19 pandemic with PMAD, specifically perinatal anxiety and depression.at multiple time points perinatally. Our study identified a significant increase in depression and anxiety scores in the postpartum period only. This observation highlights the need for increased screening and treatment for PMAD in the postpartum period as this pandemic continues. Table 3 . Unadjusted and adjusted logistic regression analyses of the association between maternal depression and anxiety and the COVID-19 pandemic. 1 Pandemic time (reference = pre-pandemic), 2 Unadjusted Odds Ratio, 3 Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic The Psychological Impact of the SARS Epidemic on Hospital Employees in China: Exposure, Risk Perception, and Altruistic Acceptance of Risk Impact of COVID-19 pandemic on mental health in the general population: A systematic review Maternal psychological distress during pregnancy and childhood health outcomes: a narrative review Parental depression and child outcomes -is marital conflict the missing link? Effects of maternal depression on family food insecurity Global burden of antenatal depression and its association with adverse birth outcomes: An umbrella review An Overview of Perinatal Mood and Anxiety Disorders: Epidemiology and Etiology Consensus Bundle on Maternal Mental Health: Perinatal Depression and Anxiety It Is Time for Routine Screening for Perinatal Mood and Anxiety Disorders in Obstetrics and Gynecology Settings Postpartum depression screening: importance, methods, barriers, and recommendations for practice Effects of gonadal steroids in women with a history of postpartum depression The prevalence of antenatal and postnatal co-morbid anxiety and depression: a meta-analysis Perinatal Mood and Anxiety Disorders Depression During Pregnancy and the Risk of Preterm Birth, Low Birth Weight, and Intrauterine Growth Restriction Association between maternal serious mental illness and adverse birthoutcomes Associations of postpartum motherinfant bonding with maternal childhood maltreatment and postpartum mental health: A crosssectional study Impact of Maternal Stress Maternal Depression During Pregnancy and the Postnatal Period: Risks and Possible Mechanisms for Offspring Depression at Age 18 Years Antenatal maternal anxiety is related to HPA-axis dysregulation and self-reported depressive symptoms in adolescence: a prospective study on the fetal origins of depressed mood Maternal antenatal anxiety and children's behavioural/emotional problems at 4 years. Report from the Avon Longitudinal Study of Parents and Children Maternal depression and cortisol in pregnancy predict offspring emotional reactivity in the preschool period Maternal pregnancy-specific anxiety is associated with child executive function at 6-9 years age Prevalence of postpartum depression and interventions utilized for its management Maternal antenatal anxiety and behavioural/emotional problems in children: a test of a programming hypothesis When the Bough Breaks: A Systematic Review and Meta-Analysis of Mental Health Symptoms in Mothers of Young Children during the COVID-19 Pandemic Depression and anxiety in pregnancy during COVID-19: A rapid review and meta-analysis The Ontario Birth Study: A prospective pregnancy cohort study integrating perinatal research into clinical care Accuracy of the Edinburgh Postnatal Depression Scale (EPDS) for screening to detect major depression among pregnant and postpartum women: systematic review and meta-analysis of individual participant data Can the Edinburgh Postnatal Depression Scale-3A be used to screen for anxiety? Adverse life events, psychiatric history, and biological predictors of postpartum depression in an ethnically diverse sample of postpartum women Women's experiences with postpartum anxiety disorders: a narrative literature review Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan The role of perceived social support on depression and sleep during the COVID-19 pandemic Stress, anxiety and depression in 1466 pregnant women during and before the COVID-19 pandemic: a Dutch cohort study Risk factors for antenatal depression, postnatal depression and parenting stress A cross-national study of factors associated with women's perinatal mental health and wellbeing during the COVID-19 pandemic Psychosocial experiences of postnatal women during the COVID-19 pandemic. A UK-wide study of prevalence rates and risk factors for clinically relevant depression and anxiety Social support and sleep: A meta-analysis Association between sleep quality and postpartum depression Sleep and postpartum depression Social support during pregnancy: effects on maternal depressive symptoms, smoking and pregnancy outcome Prolonged secretion of cortisol as a possible mechanism underlying stress and depressive behaviour Women's Mental Health in the Time of Covid-19 Pandemic. Front. Glob. Women's Heal The impact of resilience on prenatal anxiety and depression among pregnant women in Shanghai Are "Superwomen" without social support at risk for postpartum depression and anxiety? Depression, Anxiety, Resilience, and Coping: The Experience of Pregnant and New Mothers During the First Few Months of the COVID-19 Pandemic We thank and are extremely grateful to all the women who participated in the Ontario Birth Study. In addition, the authors acknowledge the contribution and support of Ontario Birth Study Team members. Table 2 . Mean ranks of perinatal maternal depression and anxiety scores before and during the COVID-19 pandemic.